Edex Live on MSN
UAE approves gene replacement therapy for wider SMA age group
The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that uses an adeno-associated viral vector to treat spinal muscular atrophy (SMA) ...
Emirates News Agency on MSN
UAE approves gene replacement therapy for new age group in spinal muscular atrophy patients
Itvisma's approval is a strategic milestone within the Emirates Drug Establishment's mission to position the UAE as a regional hub for pharmaceutical innovation by delivering advanced genetic ...
Quebec, Canada, December 20th, 2025, FinanceWireInternational clinician and integrative health researcher Oxana Ali has ...
U.S. Health Secretary Robert F. Kennedy Jr. on Tuesday added two rare genetic disorders, Duchenne Muscular Dystrophy and ...
Akhilesh Gaharwar, a biomedical engineer and one of the researchers on the project at Texs A&M, said they have found a way to ...
Teuta Hoxha says she remains determined despite growing fears for her health and five other prisoners staging protest ...
Determining which patients should receive the treatment will still require individual risk-benefit assessments, experts say.
Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy December 17, ...
The "agile, powerful, lightweight," motorcycle has been "engineered to break limits," the architectural firm told Newsweek.
Khaleej Times on MSN
UAE approves gene therapy for new age group in spinal muscular atrophy patients
The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback